What is Ceryx Medical?
Ceryx Medical is at the forefront of developing advanced bioelectronics, leveraging proprietary, patent-protected chip technology. This technology is designed to mimic the body's natural Central Pattern Generators (CPGs), which are crucial for regulating autonomic bodily functions such as peristalsis, heart rate, and locomotion. The company's innovation holds the potential to restore normal physiological processes impacted by disease or injury, offering a novel therapeutic approach in the medical technology sector.
How much funding has Ceryx Medical raised?
Ceryx Medical has raised a total of $11.6M across 2 funding rounds:
Angel/Seed
$4.8M
Other Financing Round
$6.8M
Angel/Seed (2022): $4.8M with participation from Parkwalk Advisors, Icehouse Ventures, BGF, and Development Bank of Wales
Other Financing Round (2025): $6.8M led by BGF, Parkwalk Advisors, and Development Bank of Wales
Key Investors in Ceryx Medical
Parkwalk Advisors
Parkwalk Advisors is a prominent investor in university spinouts, specializing in deeptech innovations. They provide crucial funding, expertise, and networks to help emerging technologies from UK universities achieve commercial success.
Icehouse Ventures
Icehouse Ventures, originating from NZ's first angel network, is an early-stage venture firm managing significant assets. They actively support Kiwi innovators with capital and co-investment networks to foster global competitiveness.
BGF
BGF is a leading investor in UK small and mid-sized businesses, providing capital and support to a diverse range of growing companies across various sectors and regions.
What's next for Ceryx Medical?
With the recent influx of enterprise-level backing, Ceryx Medical is poised for significant expansion and further development of its CPG technology. This strategic investment will likely fuel clinical trials, enhance manufacturing capabilities, and broaden market penetration. The company's focus on restoring autonomic functions positions it for substantial growth in the neuro-modulation and regenerative medicine markets, aiming to address unmet clinical needs with its unique bioelectronic solutions.
See full Ceryx Medical company page
